Sucampo Pharma Inc (SCMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2006 | 12-2005 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 22,481 | N/A |
| Marketable Securities | 29,399 | N/A |
| Receivables | 5,921 | N/A |
| Income taxes - deferred | 1,612 | N/A |
| TOTAL | $59,949 | $N/A |
| Non-Current Assets | ||
| PPE Net | 343 | N/A |
| Other Non-Current Assets | 6,792 | 0 |
| TOTAL | $7,135 | $N/A |
| Total Assets | $67,084 | $N/A |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 2,391 | 0 |
| Accrued Expenses | 5,418 | N/A |
| TOTAL | $19,326 | $N/A |
| Non-Current Liabilities | ||
| Deferred Revenues | 11,517 | N/A |
| Other Non-Current Liabilities | 33 | 0 |
| TOTAL | $9,225 | $N/A |
| Total Liabilities | $28,551 | $N/A |
| Shareholders' Equity | ||
| Common Shares | 350 | N/A |
| Retained earnings | -23,366 | N/A |
| Other shareholders' equity | 19,994 | 0 |
| TOTAL | $38,533 | $N/A |
| Total Liabilities And Equity | $67,084 | $0 |